Aytu BioPharma, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2011 | $58.4K | $22.8K | — |
| FY2012 | $82.4K | $12.6K | — |
| FY2013 | $120.5K | $9.7K | $2.9M |
| FY2014 | $6.6M | $12.0M | $2.6M |
| FY2015 | $2.6M | $18.2M | $7.4M |
| FY2016 | $14.3M | $24.3M | $8.1M |
| FY2017 | $11.0M | $15.0M | $802.3K |
| FY2018 | $7.6M | $21.1M | $7.0M |
| FY2019 | $27.6M | $34.7M | $11.0M |
| FY2020 | $58.3M | $153.3M | $48.1M |
| FY2021 | $128.1M | $265.7M | $49.6M |
| FY2022 | $93.3M | $137.6M | $19.4M |
| FY2023 | $97.1M | $136.5M | $23.0M |
| FY2024 | $90.4M | $118.1M | $20.0M |
| FY2025 | $105.2M | $124.2M | $31.0M |
| FY2026 | $69.7M | $105.0M | $26.3M |